BIOMAT Database Logo BIOMAT Database Logo

[Mechanism of action of different inhibitors of thrombocyte aggregation]. 1984

K M Lakin, and V A Makarov, and N V Novikova, and A G Muliar

UI MeSH Term Description Entries
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D011459 Prostaglandins E, Synthetic Analogs or derivatives of prostaglandins E that do not occur naturally in the body. They do not include the product of the chemical synthesis of hormonal PGE. PGE Synthetic,Prostaglandin E Analogs,Prostaglandin E Analogues,Synthetic Prostaglandins E,Analogs, Prostaglandin E,Analogues, Prostaglandin E,Synthetic, PGE
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D011465 Prostaglandins, Synthetic Compounds obtained by chemical synthesis that are analogs or derivatives of naturally occurring prostaglandins and that have similar activity. PG Analog,PG Analogs,Prostaglandin Analog,Prostaglandin Analogs,Prostaglandin Analogue,Synthetic Prostaglandin,Prostaglandin Analogues,Synthetic Prostaglandins,Analog, PG,Analog, Prostaglandin,Analogs, PG,Analogs, Prostaglandin,Analogue, Prostaglandin,Analogues, Prostaglandin,Prostaglandin, Synthetic
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D001808 Blood Vessels Any of the tubular vessels conveying the blood (arteries, arterioles, capillaries, venules, and veins). Blood Vessel,Vessel, Blood,Vessels, Blood
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D004336 Drug Antagonism Phenomena and pharmaceutics of compounds that inhibit the function of agonists (DRUG AGONISM) and inverse agonists (DRUG INVERSE AGONISM) for a specific receptor. On their own, antagonists produce no effect by themselves to a receptor, and are said to have neither intrinsic activity nor efficacy. Antagonism, Drug,Antagonisms, Drug,Drug Antagonisms
D004727 Endothelium A layer of epithelium that lines the heart, blood vessels (ENDOTHELIUM, VASCULAR), lymph vessels (ENDOTHELIUM, LYMPHATIC), and the serous cavities of the body. Endotheliums

Related Publications

K M Lakin, and V A Makarov, and N V Novikova, and A G Muliar
[Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
March 1979, Schweizerische medizinische Wochenschrift,
K M Lakin, and V A Makarov, and N V Novikova, and A G Muliar
Thrombocyte aggregation inhibitors are important.
January 2013, Deutsches Arzteblatt international,
K M Lakin, and V A Makarov, and N V Novikova, and A G Muliar
[Mechanism of action of platelet aggregation inhibitors].
January 2004, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
K M Lakin, and V A Makarov, and N V Novikova, and A G Muliar
[The mechanism of thrombocyte aggregation autoregulation].
May 1973, Fiziologicheskii zhurnal SSSR imeni I. M. Sechenova,
K M Lakin, and V A Makarov, and N V Novikova, and A G Muliar
[Thrombocyte aggregation inhibitors during regional anesthesia].
October 1999, Der Anaesthesist,
K M Lakin, and V A Makarov, and N V Novikova, and A G Muliar
[Use of thrombocyte aggregation inhibitors in cardiology].
December 1997, Der Internist,
K M Lakin, and V A Makarov, and N V Novikova, and A G Muliar
[Action of calcium antagonists on thrombocyte aggregation].
January 1987, Farmakologiia i toksikologiia,
K M Lakin, and V A Makarov, and N V Novikova, and A G Muliar
[Thrombocyte aggregation inhibitors: what are the risks?].
October 2013, Praxis,
K M Lakin, and V A Makarov, and N V Novikova, and A G Muliar
[Effect of aggregation inhibitors on thrombocyte enzymatic activity].
January 1978, Farmakologiia i toksikologiia,
K M Lakin, and V A Makarov, and N V Novikova, and A G Muliar
[Action of some pyrazolone derivatives on thrombocyte aggregation].
January 1976, Farmakologiia i toksikologiia,
Copied contents to your clipboard!